Jim Bush

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2

Wendy Painter, Wayne Holman, Jim Bush et al. · Antimicrobial Agents and Chemotherapy · 2021 · 399 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks

Ana Santos Cravo, Jim Bush, Girish Sharma et al. · Regulatory Toxicology and Pharmacology · 2016 · 125 citations · Full text

Pharmacy, Pharmacology, Toxicology +13

Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring

Nick L. Occleston, Sharon O’Kane, Hugh Laverty et al. · Wound Repair and Regeneration · 2011 · 79 citations

Medicine, Dermatology, Surgery +16

Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting

Tanvir Walele, Jim Bush, Annelize Koch et al. · Regulatory Toxicology and Pharmacology · 2017 · 69 citations · Full text

Medicine, Pharmacology, Pharmacovigilance +12

Randomized phase II clinical trial of avotermin <i>versus</i> placebo for scar improvement

P T McCollum, Jim Bush, G James et al. · British journal of surgery · 2011 · 47 citations · Full text

Medicine, Pharmacotherapy, Surgery +15